Capstone Investment Advisors »

Akero Therapeutics shares owned by Capstone Investment Advisors

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Capstone Investment Advisors from 13F filings

Historical chart of Capstone Investment Advisors investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by Capstone Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by Capstone Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.2M 87k 25.26

More positions owned by Capstone Investment Advisors

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Put Option (NVDA)
Microsoft Corporation Put Option (MSFT)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Meta Platforms Cl A Put Option (META)
Amazon Call Option (AMZN)
Apple Put Option (AAPL)
Tesla Motors Put Option (TSLA)
Ishares Tr Msci Emg Mkt Etf Put Option (EEM)
Select Sector Spdr Tr Financial Call Option (XLF)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Alphabet Cap Stk Cl C Call Option (GOOG)
Broadcom (AVGO)

View all positions for Capstone Investment Advisors

Top funds holding Akero Therapeutics

Henderson Group
General Atlantic
BlackRock
T. Rowe Price Associates
Vanguard Group
Wellington Management Company
Baker Bros. Advisors
Redmile Group
Boxer Capital
Alliancebernstein
Yiheng Capital
Geode Capital Management
Perceptive Advisors
Fred Alger Management
Rock Springs Capital Management

View all funds holding Akero Therapeutics